Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study.
Publication
, Conference
Gewandter, JS; Marshall, J; Brown, J; Curtis, LH; Dworkin, RH; Kleckner, I; Kolb, N; Morrow, GR; Mustian, KM; Mohile, SG
Published in: Journal of Clinical Oncology
May 20, 2018
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2018
Volume
36
Issue
15_suppl
Start / End Page
e18707 / e18707
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gewandter, J. S., Marshall, J., Brown, J., Curtis, L. H., Dworkin, R. H., Kleckner, I., … Mohile, S. G. (2018). Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study. In Journal of Clinical Oncology (Vol. 36, pp. e18707–e18707). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.e18707
Gewandter, Jennifer S., James Marshall, Jeffrey Brown, Lesley H. Curtis, Robert H. Dworkin, Ian Kleckner, Noah Kolb, Gary R. Morrow, Karen Michelle Mustian, and Supriya Gupta Mohile. “Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study.” In Journal of Clinical Oncology, 36:e18707–e18707. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e18707.
Gewandter JS, Marshall J, Brown J, Curtis LH, Dworkin RH, Kleckner I, et al. Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e18707–e18707.
Gewandter, Jennifer S., et al. “Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. e18707–e18707. Crossref, doi:10.1200/jco.2018.36.15_suppl.e18707.
Gewandter JS, Marshall J, Brown J, Curtis LH, Dworkin RH, Kleckner I, Kolb N, Morrow GR, Mustian KM, Mohile SG. Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e18707–e18707.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2018
Volume
36
Issue
15_suppl
Start / End Page
e18707 / e18707
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences